Ledger.Open graph →
SEC Form D · filed June 26, 2019

Kiadis Pharma N.V

Offering
$18.4M
Sold
$18.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AMSTERDAM, P7
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Mark Wegter · Amsterdam, P7DirectorMartijn Kleijwegt · Leiden, P7DirectorBerndt Modig · Leiden, P7DirectorDr. Robert Soiffer · Amsterdam, P7DirectorOtto Schwarz · Amsterdam, P7DirectorSubhanu Saxena · Amsterdam, P7DirectorScott A. Holmes · Amsterdam, P7ExecJames A. Joy · Amsterdam, P7ExecMark A. Schaefer · Amsterdam, P7ExecArthur Lahr · Amsterdam, P7ExecMark Wegter · Amsterdam, P7DirectorBerndt Modig · Leiden, P7DirectorMartijn Kleijwegt · Alachua, FLDirectorDr. Robert Soiffer · Amsterdam, P7DirectorOtto Schwarz · Amsterdam, P7DirectorSubhanu Saxena · Amsterdam, P7DirectorScott A. Holmes · Amsterdam, P7ExecJames A. Joy · Amsterdam, P7ExecMark A. Schaefer · Amsterdam, P7ExecArthur Lahr · Amsterdam, P7Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗